Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Apr 7:14:102.
doi: 10.1186/1471-244X-14-102.

Clozapine: a review of clinical practice guidelines and prescribing trends

Stephanie Warnez, Silvia Alessi-Severini  1
Affiliations
Review

Clozapine: a review of clinical practice guidelines and prescribing trends

Stephanie Warnez et al. BMC Psychiatry. .

Abstract

Background: Clozapine effectiveness in the treatment of refractory schizophrenia has been sustained by published evidence in the last two decades, despite the introduction of safer options.

Discussion: Current clinical practice guidelines have strongly recommended the use of clozapine in treatment-resistant schizophrenia, but prescribing trends do not appear to have followed such recommendations. Clozapine is still underutilized especially in patients at risk of suicide. It seems that physicians are hesitant in prescribing clozapine due to concerns about serious adverse effects. Recent reports have highlighted the need to inform health professionals about the benefits of treating patients with clozapine and have voiced concerns about the underutilization of clozapine especially in patients at risk of suicide.

Summary: Guidelines and prescribing patterns reported in various countries worldwide are discussed. Suggestions on how to optimize clozapine utilization have been published but more efforts are needed to properly inform and support prescribers' practices.

PubMed Disclaimer

References

    1. Crilly J. The history of clozapine and its emergence in the US market: a review and analysis. Hist Psychiatry. 2007;18(1):39–60. doi: 10.1177/0957154X07070335. - DOI - PubMed
    1. Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic, A double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988;45(9):789–796. doi: 10.1001/archpsyc.1988.01800330013001. - DOI - PubMed
    1. Clozaril. Product Monograph. Health Canada http://webprod5.hc-sc.gc.ca/dpd-bdpp/info.do?code=11421&lang=eng Accessed on January 30, 2014.
    1. Honigfeld G, Arellano F, Sethi J, Bianchini A, Schein J. Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry. J Clin Psychiatry. 1998;59(Suppl 3):3–7. - PubMed
    1. Hartling L, Abou-Setta A, Dursum S, Mousavi SS, Pasichnyk D, Newton AS. Antipsychotics in adults with schizophrenia: comparative effectiveness of first-generation versus second-generation medications. Ann Int Med. 2012;157:498–511. doi: 10.7326/0003-4819-157-7-201210020-00525. - DOI - PubMed

MeSH terms